Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Sinusitis
•
Primary Care
When would you favor initiation of mepolizumab versus dupilumab for CRSwNP?
Related Questions
When do you consider extending the dosing interval for patients on biologics with CRSwNP?
How often do you find a food allergy on a skin test in an EoE patient that when avoided will result in significant resolution of EoE?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
How do you manage recurrent epistaxis from nasal steroids?
Do you consider immunoglobulin replacement in a patient who has rapidly waning vaccine titers but does appropriately respond to revaccination?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
How do you counsel parents about the anticipated abdominal pain associated with oral desensitization in peanut-allergic children?
Do you switch from 0.15 mg to 0.3 mg epinephrine at 55lbs or 66lbs?
Would you ever use dupilumab for atopic dermatitis in a patient who also has EGPA?
